The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
Recruiting · NCT06027554 · Registry updated 2026-08-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults | Cognition Disorders, Cognitive Dysfunction, Frailty, Mild Cognitive Impairment, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cognitive disorder, psychiatric disorder | Recruiting | Phase 2 | 2026-08-12 | NCT06027554 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute on Aging (NIA) | 571 |
| UConn Health | 35 |
| University of Connecticut | 40 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Uconn Health | Farmington | United States | 26 |